313 related articles for article (PubMed ID: 15153561)
1. Late onset of treatment with a chemokine receptor CCR1 antagonist prevents progression of lupus nephritis in MRL-Fas(lpr) mice.
Anders HJ; Belemezova E; Eis V; Segerer S; Vielhauer V; Perez de Lema G; Kretzler M; Cohen CD; Frink M; Horuk R; Hudkins KL; Alpers CE; Mampaso F; Schlöndorff D
J Am Soc Nephrol; 2004 Jun; 15(6):1504-13. PubMed ID: 15153561
[TBL] [Abstract][Full Text] [Related]
2. CCR1 blockade reduces interstitial inflammation and fibrosis in mice with glomerulosclerosis and nephrotic syndrome.
Vielhauer V; Berning E; Eis V; Kretzler M; Segerer S; Strutz F; Horuk R; Gröne HJ; Schlöndorff D; Anders HJ
Kidney Int; 2004 Dec; 66(6):2264-78. PubMed ID: 15569315
[TBL] [Abstract][Full Text] [Related]
3. Delayed chemokine receptor 1 blockade prolongs survival in collagen 4A3-deficient mice with Alport disease.
Ninichuk V; Gross O; Reichel C; Khandoga A; Pawar RD; Ciubar R; Segerer S; Belemezova E; Radomska E; Luckow B; Perez de Lema G; Murphy PM; Gao JL; Henger A; Kretzler M; Horuk R; Weber M; Krombach F; Schlöndorff D; Anders HJ
J Am Soc Nephrol; 2005 Apr; 16(4):977-85. PubMed ID: 15716328
[TBL] [Abstract][Full Text] [Related]
4. Chemokine expression precedes inflammatory cell infiltration and chemokine receptor and cytokine expression during the initiation of murine lupus nephritis.
Lema GP; Maier H; Nieto E; Vielhauer V; Luckow B; Mampaso F; Schlöndorff D
J Am Soc Nephrol; 2001 Jul; 12(7):1369-1382. PubMed ID: 11423566
[TBL] [Abstract][Full Text] [Related]
5. Chemokine receptor CCR1 but not CCR5 mediates leukocyte recruitment and subsequent renal fibrosis after unilateral ureteral obstruction.
Eis V; Luckow B; Vielhauer V; Siveke JT; Linde Y; Segerer S; Perez De Lema G; Cohen CD; Kretzler M; Mack M; Horuk R; Murphy PM; Gao JL; Hudkins KL; Alpers CE; Gröne HJ; Schlöndorff D; Anders HJ
J Am Soc Nephrol; 2004 Feb; 15(2):337-47. PubMed ID: 14747380
[TBL] [Abstract][Full Text] [Related]
6. A chemokine receptor CCR-1 antagonist reduces renal fibrosis after unilateral ureter ligation.
Anders HJ; Vielhauer V; Frink M; Linde Y; Cohen CD; Blattner SM; Kretzler M; Strutz F; Mack M; Gröne HJ; Onuffer J; Horuk R; Nelson PJ; Schlöndorff D
J Clin Invest; 2002 Jan; 109(2):251-9. PubMed ID: 11805137
[TBL] [Abstract][Full Text] [Related]
7. The role of interstitial macrophages in nephropathy of type 2 diabetic db/db mice.
Ninichuk V; Khandoga AG; Segerer S; Loetscher P; Schlapbach A; Revesz L; Feifel R; Khandoga A; Krombach F; Nelson PJ; Schlöndorff D; Anders HJ
Am J Pathol; 2007 Apr; 170(4):1267-76. PubMed ID: 17392166
[TBL] [Abstract][Full Text] [Related]
8. Treatment with BX471, a nonpeptide CCR1 antagonist, protects mice against acute pancreatitis-associated lung injury by modulating neutrophil recruitment.
He M; Horuk R; Bhatia M
Pancreas; 2007 Mar; 34(2):233-41. PubMed ID: 17312463
[TBL] [Abstract][Full Text] [Related]
9. Retinoic acid treatment protects MRL/lpr lupus mice from the development of glomerular disease.
Pérez de Lema G; Lucio-Cazaña FJ; Molina A; Luckow B; Schmid H; de Wit C; Moreno-Manzano V; Banas B; Mampaso F; Schlöndorff D
Kidney Int; 2004 Sep; 66(3):1018-28. PubMed ID: 15327395
[TBL] [Abstract][Full Text] [Related]
10. Activation of toll-like receptor-9 induces progression of renal disease in MRL-Fas(lpr) mice.
Anders HJ; Vielhauer V; Eis V; Linde Y; Kretzler M; Perez de Lema G; Strutz F; Bauer S; Rutz M; Wagner H; Gröne HJ; Schlöndorff D
FASEB J; 2004 Mar; 18(3):534-6. PubMed ID: 14734643
[TBL] [Abstract][Full Text] [Related]
11. Chemokine receptor Ccr2 deficiency reduces renal disease and prolongs survival in MRL/lpr lupus-prone mice.
Pérez de Lema G; Maier H; Franz TJ; Escribese M; Chilla S; Segerer S; Camarasa N; Schmid H; Banas B; Kalaydjiev S; Busch DH; Pfeffer K; Mampaso F; Schlöndorff D; Luckow B
J Am Soc Nephrol; 2005 Dec; 16(12):3592-601. PubMed ID: 16267157
[TBL] [Abstract][Full Text] [Related]
12. Treatment with BX471, a CC chemokine receptor 1 antagonist, attenuates systemic inflammatory response during sepsis.
He M; Horuk R; Moochhala SM; Bhatia M
Am J Physiol Gastrointest Liver Physiol; 2007 Apr; 292(4):G1173-80. PubMed ID: 17234893
[TBL] [Abstract][Full Text] [Related]
13. Protective role for CCR5 in murine lupus nephritis.
Turner JE; Paust HJ; Bennstein SB; Bramke P; Krebs C; Steinmetz OM; Velden J; Haag F; Stahl RA; Panzer U
Am J Physiol Renal Physiol; 2012 Jun; 302(11):F1503-15. PubMed ID: 22442210
[TBL] [Abstract][Full Text] [Related]
14. IL-12 deficiency in MRL-Fas(lpr) mice delays nephritis and intrarenal IFN-gamma expression, and diminishes systemic pathology.
Kikawada E; Lenda DM; Kelley VR
J Immunol; 2003 Apr; 170(7):3915-25. PubMed ID: 12646661
[TBL] [Abstract][Full Text] [Related]
15. Enhanced osteopontin expression and macrophage infiltration in MRL-Fas(lpr) mice with lupus nephritis.
Wüthrich RP; Fan X; Ritthaler T; Sibalic V; Yu DJ; Loffing J; Kaissling B
Autoimmunity; 1998; 28(3):139-50. PubMed ID: 9867126
[TBL] [Abstract][Full Text] [Related]
16. Distinct expression of CCR1 and CCR5 in glomerular and interstitial lesions of human glomerular diseases.
Furuichi K; Wada T; Sakai N; Iwata Y; Yoshimoto K; Shimizu M; Kobayashi K; Takasawa K; Kida H; Takeda SI; Mukaida N; Matsushima K; Yokoyama H
Am J Nephrol; 2000; 20(4):291-9. PubMed ID: 10970982
[TBL] [Abstract][Full Text] [Related]
17. CCR5 deficiency aggravates crescentic glomerulonephritis in mice.
Turner JE; Paust HJ; Steinmetz OM; Peters A; Meyer-Schwesinger C; Heymann F; Helmchen U; Fehr S; Horuk R; Wenzel U; Kurts C; Mittrücker HW; Stahl RA; Panzer U
J Immunol; 2008 Nov; 181(9):6546-56. PubMed ID: 18941245
[TBL] [Abstract][Full Text] [Related]
18. Viral double-stranded RNA aggravates lupus nephritis through Toll-like receptor 3 on glomerular mesangial cells and antigen-presenting cells.
Patole PS; Gröne HJ; Segerer S; Ciubar R; Belemezova E; Henger A; Kretzler M; Schlöndorff D; Anders HJ
J Am Soc Nephrol; 2005 May; 16(5):1326-38. PubMed ID: 15772251
[TBL] [Abstract][Full Text] [Related]
19. Lack of chemokine receptor CCR1 enhances Th1 responses and glomerular injury during nephrotoxic nephritis.
Topham PS; Csizmadia V; Soler D; Hines D; Gerard CJ; Salant DJ; Hancock WW
J Clin Invest; 1999 Dec; 104(11):1549-57. PubMed ID: 10587518
[TBL] [Abstract][Full Text] [Related]
20. Amelioration of autoimmune nephritis by imatinib in MRL/lpr mice.
Sadanaga A; Nakashima H; Masutani K; Miyake K; Shimizu S; Igawa T; Sugiyama N; Niiro H; Hirakata H; Harada M
Arthritis Rheum; 2005 Dec; 52(12):3987-96. PubMed ID: 16320345
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
